HpARI Protein Secreted by a Helminth Parasite Suppresses Interleukin-33
Overview
Authors
Affiliations
Infection by helminth parasites is associated with amelioration of allergic reactivity, but mechanistic insights into this association are lacking. Products secreted by the mouse parasite Heligmosomoides polygyrus suppress type 2 (allergic) immune responses through interference in the interleukin-33 (IL-33) pathway. Here, we identified H. polygyrus Alarmin Release Inhibitor (HpARI), an IL-33-suppressive 26-kDa protein, containing three predicted complement control protein (CCP) modules. In vivo, recombinant HpARI abrogated IL-33, group 2 innate lymphoid cell (ILC2) and eosinophilic responses to Alternaria allergen administration, and diminished eosinophilic responses to Nippostrongylus brasiliensis, increasing parasite burden. HpARI bound directly to both mouse and human IL-33 (in the cytokine's activated state) and also to nuclear DNA via its N-terminal CCP module pair (CCP1/2), tethering active IL-33 within necrotic cells, preventing its release, and forestalling initiation of type 2 allergic responses. Thus, HpARI employs a novel molecular strategy to suppress type 2 immunity in both infection and allergy.
Yu L, Yang W, Liang Y Biomedicines. 2025; 12(12.
PMID: 39767678 PMC: 11673925. DOI: 10.3390/biomedicines12122771.
European Respiratory Society Research Seminar on Preventing Pediatric Asthma.
Grigg J, Barratt B, Bonnelykke K, Custovic A, Ege M, Pasquali C Pediatr Pulmonol. 2024; 60(1):e27401.
PMID: 39625247 PMC: 11748117. DOI: 10.1002/ppul.27401.
Critical and diverse role of alarmin cytokines in parasitic infections.
Xing Z, Liu S, He X Front Cell Infect Microbiol. 2024; 14:1418500.
PMID: 39559705 PMC: 11570582. DOI: 10.3389/fcimb.2024.1418500.
Heparan sulphate binding controls in vivo half-life of the HpARI protein family.
Colomb F, Jamwal A, Ogunkanbi A, Frangova T, Savage A, Kelly S Elife. 2024; 13.
PMID: 39514278 PMC: 11548879. DOI: 10.7554/eLife.99000.
Regulation of Airway Epithelial-Derived Alarmins in Asthma: Perspectives for Therapeutic Targets.
Hansi R, Ranjbar M, Whetstone C, Gauvreau G Biomedicines. 2024; 12(10).
PMID: 39457624 PMC: 11505104. DOI: 10.3390/biomedicines12102312.